Form 8-K - Current report:
SEC Accession No. 0001104659-16-122569
Filing Date
2016-05-23
Accepted
2016-05-23 11:32:36
Documents
3
Period of Report
2016-05-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-11429_28k.htm 8-K 19915
2 EX-99.1 a16-11429_2ex99d1.htm EX-99.1 19632
3 EX-99.2 a16-11429_2ex99d2.htm EX-99.2 14999
  Complete submission text file 0001104659-16-122569.txt   55858
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 161668223
SIC: 2834 Pharmaceutical Preparations